CAS
LLY icon

CTC Alternative Strategies’s Eli Lilly LLY Stock Holding History

CTC Alternative Strategies’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,300
Closed -$1M – 111
2024
Q4 		$1M Buy
1,300
+674
+108% +$558K 1.21% 15
2024
Q3 		$555K Buy
+626
New +$563K 0.69% 22
2013
Q3 		– Sell
-9,900
Closed -$486K – 148
2013
Q2 		$486K Buy
+9,900
New +$539K 0.13% 63

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CTC Alternative Strategies's LLY Position: Q1 2025 in Review

CTC Alternative Strategies sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 1,300 shares — an estimated $1M sold.

CTC Alternative Strategies first reported a position in LLY in Q2 2013 and held it in 3 quarters. The position peaked at $1M in Q4 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • CTC Alternative Strategies reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • CTC Alternative Strategies sold 1,300 Eli Lilly shares in Q1 2025, an estimated $1M.
  • CTC Alternative Strategies first reported a position in Eli Lilly in Q2 2013 and held it in 3 quarters.
  • CTC Alternative Strategies's Eli Lilly position peaked at $1M in Q4 2024.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on CTC Alternative Strategies's 13F filing for Q1 2025, filed 16 May 2025.